-
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts
Source: Buzz FX / 15 Jan 2025 02:56:16 America/New_York
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Shares of Immunome, Inc. ( NASDAQ:IMNM - Get Free Report ) have been assigned an average rating
Read more...